Your browser doesn't support javascript.
loading
Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase-4 Inhibitor: A Randomized, Double-Blinded, Placebo-Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus.
Wu, Min; Li, Qian-Qian; Zhang, Hong; Zhu, Xiao-Xue; Li, Xiao-Jiao; Li, Ying; Sun, Hai-Gang; Ding, Yan-Hua.
Afiliação
  • Wu M; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
  • Li QQ; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhang H; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhu XX; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
  • Li XJ; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
  • Li Y; Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen, Guangdong, China.
  • Sun HG; Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen, Guangdong, China.
  • Ding YH; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.
Clin Pharmacol Drug Dev ; 10(6): 660-668, 2021 06.
Article em En | MEDLINE | ID: mdl-33440080
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Triazinas / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Triazinas / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos